{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:22:30Z","timestamp":1792167750684,"version":"4.4.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T00:00:00Z","timestamp":1680739200000},"content-version":"vor","delay-in-days":370,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017547","name":"Spark Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017547","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007817","name":"Alcon Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007817","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012233","name":"Abeona Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012233","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016618","name":"Gilbert Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016618","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5P30CA013696"],"award-info":[{"award-number":["5P30CA013696"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5P30EY019007"],"award-info":[{"award-number":["5P30EY019007"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01EY018213"],"award-info":[{"award-number":["R01EY018213"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01EY024698"],"award-info":[{"award-number":["R01EY024698"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01EY026682"],"award-info":[{"award-number":["R01EY026682"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AG050437"],"award-info":[{"award-number":["R21AG050437"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R24EY027285"],"award-info":[{"award-number":["R24EY027285"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R24EY028758"],"award-info":[{"award-number":["R24EY028758"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 EY030580"],"award-info":[{"award-number":["U01 EY030580"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54OD020351"],"award-info":[{"award-number":["U54OD020351"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.ymthe.2022.02.010","type":"journal-article","created":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T21:40:08Z","timestamp":1644442808000},"page":"1407-1420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa"],"prefix":"10.1016","volume":"30","author":[{"given":"Wen-Hsuan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ting","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Wen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3792-2327","authenticated-orcid":false,"given":"Chia-Hua","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Wei","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5449-2395","authenticated-orcid":false,"given":"Joseph","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9940-4264","authenticated-orcid":false,"given":"Peter M.J.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1368-1178","authenticated-orcid":false,"given":"Salvatore Marco","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6318-3743","authenticated-orcid":false,"given":"Chyuang-Sheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9082-2427","authenticated-orcid":false,"given":"Stephen H.","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2022.02.010_bib1","doi-asserted-by":"crossref","first-page":"15112","DOI":"10.1073\/pnas.0807027105","article-title":"Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics","volume":"105","author":"Cideciyan","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ymthe.2022.02.010_bib2","doi-asserted-by":"crossref","first-page":"E517","DOI":"10.1073\/pnas.1218933110","article-title":"Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement","volume":"110","author":"Cideciyan","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ymthe.2022.02.010_bib3","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa1412965","article-title":"Improvement and decline in vision with gene therapy in childhood blindness","volume":"372","author":"Jacobson","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2022.02.010_bib4","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1056\/NEJMe1503419","article-title":"Long-term effects of retinal gene therapy in childhood blindness","volume":"372","author":"Wright","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2022.02.010_bib5","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/mt.2015.220","article-title":"In\u00a0vivo CRISPR\/Cas9 gene editing corrects retinal dystrophy in the S334ter-3 rat model of autosomal dominant retinitis pigmentosa","volume":"24","author":"Bakondi","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2022.02.010_bib6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/gt.2011.172","article-title":"Gene-based therapies for dominantly inherited retinopathies","volume":"19","author":"Farrar","year":"2012","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2022.02.010_bib7","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/hmg\/ddx438","article-title":"Cas9\/sgRNA selective targeting of the P23H Rhodopsin mutant allele for treating retinitis pigmentosa by intravitreal AAV9.PHP.B-based delivery","volume":"27","author":"Giannelli","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2022.02.010_bib8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1087-0024.2005.10207.x","article-title":"Gene therapy for autosomal dominant disorders of keratin","volume":"10","author":"Lewin","year":"2005","journal-title":"J.\u00a0Investig. Dermatol. Symp. Proc."},{"key":"10.1016\/j.ymthe.2022.02.010_bib9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1089\/crispr.2017.0009","article-title":"Allele-specific CRISPR-Cas9 genome editing of the single-base P23H mutation for rhodopsin-associated dominant retinitis pigmentosa","volume":"1","author":"Li","year":"2018","journal-title":"CRISPR J."},{"key":"10.1016\/j.ymthe.2022.02.010_bib10","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1093\/hmg\/6.9.1415","article-title":"Strategems in\u00a0vitro for gene therapies directed to dominant mutations","volume":"6","author":"Millington-Ward","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2022.02.010_bib11","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s10529-018-2555-y","article-title":"Therapeutic applications of CRISPR\/Cas9 system in gene therapy","volume":"40","author":"Mollanoori","year":"2018","journal-title":"Biotechnol. Lett."},{"key":"10.1016\/j.ymthe.2022.02.010_bib12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nm.3793","article-title":"Therapeutic genome editing: prospects and challenges","volume":"21","author":"Cox","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2022.02.010_bib13","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature20134","article-title":"CRISPR\/Cas9 beta-globin gene targeting in human haematopoietic stem cells","volume":"539","author":"Dever","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2022.02.010_bib14","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nature23305","article-title":"Correction of a pathogenic gene mutation in human embryos","volume":"548","author":"Ma","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2022.02.010_bib15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nrn.2015.2","article-title":"Applications of CRISPR-Cas systems in neuroscience","volume":"17","author":"Heidenreich","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ymthe.2022.02.010_bib16","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1038\/s41598-019-39142-0","article-title":"Unlocking HDR-mediated nucleotide editing by identifying high-efficiency target sites using machine learning","volume":"9","author":"O'Brien","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2022.02.010_bib17","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/abbs\/gmx055","article-title":"Cell cycle-dependent control of homologous recombination","volume":"49","author":"Zhao","year":"2017","journal-title":"Acta Biochim. Biophys. Sin (Shanghai)"},{"key":"10.1016\/j.ymthe.2022.02.010_bib18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-3-030-27378-1_19","article-title":"Progress in gene therapy for rhodopsin autosomal dominant retinitis pigmentosa","volume":"1185","author":"Sudharsan","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ymthe.2022.02.010_bib19","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/j.ymthe.2020.08.012","article-title":"Therapy in rhodopsin-mediated autosomal dominant retinitis pigmentosa","volume":"28","author":"Meng","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2022.02.010_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2017.10.002","article-title":"The molecular and cellular basis of rhodopsin retinitis pigmentosa reveals potential strategies for therapy","volume":"62","author":"Athanasiou","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ymthe.2022.02.010_bib30","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.ophtha.2018.04.001","article-title":"Clustered regularly interspaced short palindromic repeats-based genome surgery for the treatment of autosomal dominant retinitis pigmentosa","volume":"125","author":"Tsai","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2022.02.010_bib21","doi-asserted-by":"crossref","first-page":"e96560","DOI":"10.1172\/jci.insight.96560","article-title":"Targeting and silencing of rhodopsin by ectopic expression of the transcription factor KLF15","volume":"2","author":"Botta","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymthe.2022.02.010_bib22","doi-asserted-by":"crossref","first-page":"e12242","DOI":"10.7554\/eLife.12242","article-title":"Rhodopsin targeted transcriptional silencing by DNA-binding","volume":"5","author":"Botta","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.ymthe.2022.02.010_bib23","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/mt.2008.301","article-title":"Improved retinal function in a mouse model of dominant retinitis pigmentosa following AAV-delivered gene therapy","volume":"17","author":"Chadderton","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2022.02.010_bib24","doi-asserted-by":"crossref","first-page":"9109","DOI":"10.1073\/pnas.0403149101","article-title":"Knock-in human rhodopsin-GFP fusions as mouse models for human disease and targets for gene therapy","volume":"101","author":"Chan","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ymthe.2022.02.010_bib25","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/mt.2010.293","article-title":"Suppression and replacement gene therapy for autosomal dominant disease in a murine model of dominant retinitis pigmentosa","volume":"19","author":"Millington-Ward","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2022.02.010_bib26","doi-asserted-by":"crossref","first-page":"9728","DOI":"10.1167\/iovs.11-8654","article-title":"Mislocalization and degradation of human P23H-rhodopsin-GFP in a knockin mouse model of retinitis pigmentosa","volume":"52","author":"Price","year":"2011","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2022.02.010_bib27","doi-asserted-by":"crossref","first-page":"8459","DOI":"10.1073\/pnas.85.22.8459","article-title":"Cysteine residues 110 and 187 are essential for the formation of correct structure in bovine rhodopsin","volume":"85","author":"Karnik","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ymthe.2022.02.010_bib28","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1073\/pnas.91.9.4029","article-title":"Structure and function in rhodopsin: replacement by alanine of cysteine residues 110 and 187, components of a conserved disulfide bond in rhodopsin, affects the light-activated metarhodopsin II state","volume":"91","author":"Davidson","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ymthe.2022.02.010_bib29","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/13816810902962405","article-title":"Rhodopsin: the functional significance of asn-linked glycosylation and other post-translational modifications","volume":"30","author":"Murray","year":"2009","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.ymthe.2022.02.010_bib31","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/978-1-4614-0631-0_26","article-title":"Functional rescue of P23H rhodopsin photoreceptors by gene delivery","volume":"723","author":"Gorbatyuk","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ymthe.2022.02.010_bib32","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/bioinformatics\/btw561","article-title":"Cas-analyzer: an online tool for assessing genome editing results using NGS data","volume":"33","author":"Park","year":"2017","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ymthe.2022.02.010_bib33","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1172\/JCI65654","article-title":"Viral-mediated RdCVF and RdCVFL expression protects cone and rod photoreceptors in retinal degeneration","volume":"125","author":"Byrne","year":"2015","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.ymthe.2022.02.010_bib34","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1089\/hum.2011.213","article-title":"Long-term rescue of retinal structure and function by rhodopsin RNA replacement with a single adeno-associated viral vector in P23H RHO transgenic mice","volume":"23","author":"Mao","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2022.02.010_bib35","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/emmm.201000119","article-title":"Zinc-finger-based transcriptional repression of rhodopsin in a model of dominant retinitis pigmentosa","volume":"3","author":"Mussolino","year":"2011","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2022.02.010_bib36","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.lfs.2015.10.025","article-title":"Men and mice: relating their ages","volume":"152","author":"Dutta","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.ymthe.2022.02.010_bib37","doi-asserted-by":"crossref","first-page":"117242","DOI":"10.1016\/j.lfs.2019.117242","article-title":"Correlation between mouse age and human age in anti-tumor research: significance and method establishment","volume":"242","author":"Wang","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.ymthe.2022.02.010_bib38","doi-asserted-by":"crossref","first-page":"e0188032","DOI":"10.1371\/journal.pone.0188032","article-title":"Long-term retinal cone rescue using a capsid mutant AAV8 vector in a mouse model of CNGA3-achromatopsia","volume":"12","author":"Dai","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2022.02.010_bib39","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/mt.2010.273","article-title":"Long-term retinal function and structure rescue using capsid mutant AAV8 vector in the rd10 mouse, a model of recessive retinitis pigmentosa","volume":"19","author":"Pang","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2022.02.010_bib40","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/mt.2008.269","article-title":"High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors","volume":"17","author":"Petrs-Silva","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2022.02.010_bib41","doi-asserted-by":"crossref","first-page":"E8547","DOI":"10.1073\/pnas.1805055115","article-title":"Mutation-independent rhodopsin gene therapy by knockdown and replacement with a single AAV vector","volume":"115","author":"Cideciyan","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ymthe.2022.02.010_bib42","doi-asserted-by":"crossref","first-page":"6362","DOI":"10.1167\/iovs.15-16400","article-title":"Allele-specific inhibition of rhodopsin with an antisense oligonucleotide slows photoreceptor cell degeneration","volume":"56","author":"Murray","year":"2015","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2022.02.010_bib43","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/ng0297-216","article-title":"Retinopathy induced in mice by targeted disruption of the rhodopsin gene","volume":"15","author":"Humphries","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2022.02.010_bib44","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41551-019-0357-8","article-title":"Adenine base editing in an adult mouse model of tyrosinaemia","volume":"4","author":"Song","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ymthe.2022.02.010_bib45","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41551-020-00632-6","article-title":"Restoration of visual function in adult mice with an inherited retinal disease via adenine base editing","volume":"5","author":"Suh","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ymthe.2022.02.010_bib46","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3390\/genes11050511","article-title":"Efficient generation and correction of mutations in human iPS cells utilizing mRNAs of CRISPR base editors and prime editors","volume":"11","author":"Surun","year":"2020","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.ymthe.2022.02.010_bib47","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1038\/s41591-018-0209-1","article-title":"Treatment of a metabolic liver disease by in\u00a0vivo genome base editing in adult mice","volume":"24","author":"Villiger","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2022.02.010_bib48","doi-asserted-by":"crossref","first-page":"6240","DOI":"10.3390\/ijms21176240","article-title":"CRISPR-Cas9 DNA base-editing and prime-editing","volume":"21","author":"Kantor","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2022.02.010_bib49","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2022.02.010_bib50","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41576-018-0059-1","article-title":"Base editing: precision chemistry on the genome and transcriptome of living cells","volume":"19","author":"Rees","year":"2018","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ymthe.2022.02.010_bib51","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","article-title":"Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors","volume":"38","author":"Anzalone","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2022.02.010_bib52","doi-asserted-by":"crossref","first-page":"5352","DOI":"10.1038\/s41467-020-19136-7","article-title":"Prime editing for functional repair in patient-derived disease models","volume":"11","author":"Schene","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2022.02.010_bib53","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/gt.2012.53","article-title":"Mutation-independent rescue of a novel mouse model of Retinitis Pigmentosa","volume":"20","author":"Greenwald","year":"2013","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2022.02.010_bib54","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature04791","article-title":"Fatality in mice due to oversaturation of cellular microRNA\/short hairpin RNA pathways","volume":"441","author":"Grimm","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2022.02.010_bib55","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nbt.1543","article-title":"Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs","volume":"27","author":"Khan","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2022.02.010_bib56","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1261\/rna.28106","article-title":"Off-target effects by siRNA can induce toxic phenotype","volume":"12","author":"Fedorov","year":"2006","journal-title":"RNA"},{"key":"10.1016\/j.ymthe.2022.02.010_bib57","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nbt831","article-title":"Expression profiling reveals off-target gene regulation by RNAi","volume":"21","author":"Jackson","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2022.02.010_bib58","doi-asserted-by":"crossref","first-page":"e2003213","DOI":"10.1371\/journal.pbio.2003213","article-title":"Evaluation of RNAi and CRISPR technologies by large-scale gene expression profiling in the Connectivity Map","volume":"15","author":"Smith","year":"2017","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ymthe.2022.02.010_bib59","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.omtm.2021.02.005","article-title":"In\u00a0vivo PCSK9 gene editing using an all-in-one self-cleavage AAV-CRISPR system","volume":"20","author":"Li","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2022.02.010_bib60","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1089\/hum.2021.013","article-title":"CRISPR\/Cas-Dependent and nuclease-free in\u00a0vivo therapeutic gene editing","volume":"32","author":"Dasgupta","year":"2021","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2022.02.010_bib61","doi-asserted-by":"crossref","first-page":"e389","DOI":"10.1038\/mtna.2016.92","article-title":"In\u00a0vivo editing of the human mutant rhodopsin gene by electroporation of plasmid-based CRISPR\/Cas9 in the mouse retina","volume":"5","author":"Latella","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2022.02.010_bib62","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.stem.2014.10.004","article-title":"Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR\/Cas9","volume":"15","author":"Mandal","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2022.02.010_bib63","doi-asserted-by":"crossref","first-page":"9554","DOI":"10.3748\/wjg.v21.i32.9554","article-title":"Dual gRNAs guided CRISPR\/Cas9 system inhibits hepatitis B virus replication","volume":"21","author":"Wang","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ymthe.2022.02.010_bib64","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.oret.2021.03.016","article-title":"Perifoveal Chorioretinal atrophy after subretinal voretigene neparvovec-rzyl for RPE65-mediated leber congenital amaurosis","volume":"6","author":"Gange","year":"2021","journal-title":"Ophthalmol. Retina"},{"key":"10.1016\/j.ymthe.2022.02.010_bib65","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMoa2031054","article-title":"CRISPR-Cas9 gene editing for sickle cell disease and beta-thalassemia","volume":"384","author":"Frangoul","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2022.02.010_bib66","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.molmed.2020.06.001","article-title":"First trial of CRISPR-edited T\u00a0cells in lung cancer","volume":"26","author":"Lacey","year":"2020","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ymthe.2022.02.010_bib67","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.ymthe.2020.06.001","article-title":"Long-term follow-up of the first in human intravascular delivery of AAV for gene transfer: AAV2-hFIX16 for severe hemophilia B","volume":"28","author":"George","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2022.02.010_bib68","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1056\/NEJMoa1108046","article-title":"Adenovirus-associated virus vector-mediated gene transfer in hemophilia B","volume":"365","author":"Nathwani","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2022.02.010_bib69","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.ophtha.2019.06.017","article-title":"Efficacy, safety, and durability of voretigene neparvovec-rzyl in RPE65 mutation-associated inherited retinal dystrophy: results of phase 1 and 3 trials","volume":"126","author":"Maguire","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2022.02.010_bib70","doi-asserted-by":"crossref","first-page":"14176","DOI":"10.1073\/pnas.93.24.14176","article-title":"Transgenic mice carrying the dominant rhodopsin mutation P347S: evidence for defective vectorial transport of rhodopsin to the outer segments","volume":"93","author":"Li","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ymthe.2022.02.010_bib71","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0896-6273(92)90236-7","article-title":"Transgenic mice with a rhodopsin mutation (Pro23His): a mouse model of autosomal dominant retinitis pigmentosa","volume":"9","author":"Olsson","year":"1992","journal-title":"Neuron"},{"key":"10.1016\/j.ymthe.2022.02.010_bib72","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2119\/molmed.2011.00475","article-title":"Mice with a D190N mutation in the gene encoding rhodopsin: a model for human autosomal-dominant retinitis pigmentosa","volume":"18","author":"Sancho-Pelluz","year":"2012","journal-title":"Mol. Med."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001622000934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001622000934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:04:55Z","timestamp":1761501895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001622000934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":72,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S1525001622000934"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2022.02.010","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2022.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}